Are AndroGel Heart Attacks the Tip of the Iceberg?
Study Finds Links High Testosterone Levels to Prostate Problems
Learn How to Report Testosterone Drug Side-Effects to the FDA
By the age of 80, nine out of ten American men will experience prostate enlargement or benign prostatic hyperplasia (BPH). About half of men diagnosed with BPH require medical attention for urinary tract symptoms.
Until recently, the causes of BPH were poorly understood. However, a new study conducted by scientists at UC Santa Barbara (UCSB), has found that unnaturally high testosterone levels may be a factor.
The researchers studied men belonging to the Tsimane, an isolated indigenous population in central Bolivia. There were no cases of prostate enlargement among the 350 adult males who participated in the study. And, on average, the Tsimane men had prostates that were 62 percent smaller than those of men the same age in the United States. Why was there such a difference in prostate health?
The UCSB researchers already knew that men who don’t produce testosterone have low levels of BPH. They found that Tsimane men have testosterone levels that are 30 percent lower than age-matched American men, and that testosterone levels remain low throughout the Tsimane men’s lives. Tsimane men also have low rates of obesity, heart disease, hypertension and metabolic disease like diabetes.
Among the Tsimane men, those with higher testosterone levels did have larger prostates, but both testosterone levels and prostate size were still significantly lower than those of men in the U.S. This indicates that testosterone levels are directly related to prostate size. What does this mean for the millions of American men who use testosterone replacement therapy to treat age-related low-T?
Low-T Drugs May Increase Risk of Prostate Enlargement
Study author Benjamin Trumble says that men who use testosterone drugs are “entering themselves into an uncontrolled experiment.” There is already evidence that testosterone drugs are linked to heart attack and stroke. But, Trumble believes that side-effects could go beyond increased cardiovascular risk. He compares testosterone therapy to estrogen replacement therapy.
In the 1980’s, millions of women were given estrogen replacement drugs to ease the symptoms of menopause. In the early 2000’s, it was discovered that these women were at an increased risk for breast cancer and other cancers.
Trumble says that more long-term studies are needed to fully understand the risks of testosterone replacement therapy. In the meantime, these drugs should only be used when medically necessary. The study was published in Journals of Gerontology: Medical Sciences.
Can I Sue the Maker of AndroGel for My Prostate Problems?
At this time, there is no clinical evidence linking testosterone therapy to prostate enlargement. But, this could change in the future. If you’ve suffered were diagnosed with prostate enlargement or benign prostatic hyperplasia while taking testosterone drugs, you can make a report to the FDA.
Making a report to the FDA is easy. You simply fill out a printable form and mail it to MedWatch, Food and drug Administration, 5600 Fishers Lane, Rockville, MD 20857. You can also make an online report. The FDA uses these reports to identify potential problems.
The Drug safety Lawyers are not taking testosterone prostate cancer cases at this time, but we are representing men who have suffered heart attacks, strokes and blood clots after testosterone therapy. If you suffered cardiovascular side-effects while using low-T drugs, please call 888-808-1340 to discuss your case.